ICAM1 and diabetes mellitus: Interestingly, selective inhibition of NF-κB activation with dehydroxymethylepoxyquinomicin inhibited diabetes-induced retinal leukostasis and retinal expressions of ICAM-1 and VEGF in vivo [41].